Abstract

Drugs of abuse represent a growing public health crisis. Accumulating evidence indicates that gabapentin (GBP), a prescription drug, is prone to misuse, abuse, withdrawal, and dependence. Commonly, drugs of abuse modulate the dopaminergic system to induce addiction. In this study, we used the conditioned place preference (CPP) model to investigate the involvement of the dopamine 1 (D1) receptor on the reward and reinforcement behavior of GBP. Under a CPP paradigm, male BALB/c mice were intraperitoneally injected either saline or 100, 200, or 300 mg/kg of GBP and confined to the injection-paired chamber for 30 min. In the pre-conditioning phase, mice were conditioned for 3 days, and baseline data were collected. In the conditioning phase, mice were given once-daily alternating injections of either GBP or saline for 8 days and subsequently assessed in a post-conditioning test. Injections of 300 mg/kg of GBP significantly increased the time spent in the drug-paired chamber compared to the saline-paired chamber. However, lower doses of GBP (100 and 200 mg/kg) showed no effect. Pre-treatment with SKF-83566, a D1 receptor antagonist, attenuated GBP-induced CPP. Thus, for the first time, we show that GBP can induce CPP through a dopaminergic-dependent mechanism.

Details

Title
Gabapentin-induced drug-seeking-like behavior: a potential role for the dopaminergic system
Author
Althobaiti, Yusuf S 1 ; Alghorabi Amal 2 ; Alshehri, Fahad S 3 ; Baothman Bandar 4 ; Almalki, Atiah H 5 ; Alsaab, Hashem O 6 ; Alsanie Walaa 7 ; Gaber, Ahmed 8 ; Almalki Hussam 2 ; Alghamdi, Abdulrahman S 2 ; Basfer Ahmad 2 ; Sultan, Althobaiti 9 ; Hardy Ana Maria Gregio 10 ; Shah, Zahoor A 11 

 Taif University, Department of Pharmacology and Toxicology, College of Pharmacy, Taif, Saudi Arabia (GRID:grid.412895.3) (ISNI:0000 0004 0419 5255); Taif University, Addiction and Neuroscience Research Unit, Biomedical Sciences Research Center, Taif, Saudi Arabia (GRID:grid.412895.3) (ISNI:0000 0004 0419 5255); Ministry of Interior, General Directorate of Narcotics Control, General Administration for Precursors and Laboratories, Riyadh, Saudi Arabia (GRID:grid.412895.3) 
 Taif University, Addiction and Neuroscience Research Unit, Biomedical Sciences Research Center, Taif, Saudi Arabia (GRID:grid.412895.3) (ISNI:0000 0004 0419 5255) 
 Umm Al-Qura University, Department of Pharmacology and Toxicology, College of Pharmacy, Makkah, Saudi Arabia (GRID:grid.412832.e) (ISNI:0000 0000 9137 6644) 
 Taif University, Addiction and Neuroscience Research Unit, Biomedical Sciences Research Center, Taif, Saudi Arabia (GRID:grid.412895.3) (ISNI:0000 0004 0419 5255); Taif University, Deanship of Scientific Research, Taif, Saudi Arabia (GRID:grid.412895.3) (ISNI:0000 0004 0419 5255) 
 Taif University, Addiction and Neuroscience Research Unit, Biomedical Sciences Research Center, Taif, Saudi Arabia (GRID:grid.412895.3) (ISNI:0000 0004 0419 5255); Taif University, Department of Pharmaceutical Chemistry, College of Pharmacy, Taif, Saudi Arabia (GRID:grid.412895.3) (ISNI:0000 0004 0419 5255) 
 Taif University, Addiction and Neuroscience Research Unit, Biomedical Sciences Research Center, Taif, Saudi Arabia (GRID:grid.412895.3) (ISNI:0000 0004 0419 5255); Taif University, Department of Pharmaceutics and Pharmaceutical Technology, College of Pharmacy, Taif, Saudi Arabia (GRID:grid.412895.3) (ISNI:0000 0004 0419 5255) 
 Taif University, Addiction and Neuroscience Research Unit, Biomedical Sciences Research Center, Taif, Saudi Arabia (GRID:grid.412895.3) (ISNI:0000 0004 0419 5255); Taif University, Department of Clinical Laboratories Science, Faculty of Applied Medical Sciences, Taif, Saudi Arabia (GRID:grid.412895.3) (ISNI:0000 0004 0419 5255) 
 Taif University, Addiction and Neuroscience Research Unit, Biomedical Sciences Research Center, Taif, Saudi Arabia (GRID:grid.412895.3) (ISNI:0000 0004 0419 5255); Taif University, Department of Biology, Faculty of Science, Taif, Saudi Arabia (GRID:grid.412895.3) (ISNI:0000 0004 0419 5255) 
 Ministry of Health, Department of Pharmaceutical Care, Directorate of Health Affairs, Taif, Saudi Arabia (GRID:grid.415696.9) 
10  University of Toledo, Department of Physiology and Pharmacology, College of Medicine and Life Sciences, Toledo, USA (GRID:grid.267337.4) (ISNI:0000 0001 2184 944X) 
11  University of Toledo, Department of Medicinal and Biological Chemistry, College of Pharmacy and Pharmaceutical Sciences, Toledo, USA (GRID:grid.267337.4) (ISNI:0000 0001 2184 944X) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2417700019
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.